Ian F. Smith, EVP & CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,084 shares at $89.90 ($1.1M) on 2016-02-03, disclosed to the SEC on 2016-02-04.
Scheduled sale ($1.1M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.90 | 5,000 | $450K | 40.9% |
| 2 | $90.97 | 4,232 | $385K | 35.1% |
| 3 | $91.68 | 1,200 | $110K | 10.0% |
| 4 | $92.73 | 1,652 | $153K | 14.0% |
| Total | $90.84 avg | 12,084 | $1.1M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |